Topics

Articles

Peer-reviewed study correlates adverse drug events (ADEs) with form of drug administration; can pharma manufacturers help?

Medication errors from injectable drugs are a $2.7-5.1-billion problem for US hospitals

New study magnifies the lost opportunity for industry eighteen-fold; the global gap is $564 billion

Medication non-adherence is a $188-billion revenue gap for pharma, says Capgemini

The new insurance exchanges are bound to impact industry rebates - and therefore the ability to manage financial reporting, says PwC Health Research Institute

Getting ready for health exchanges - or not

A conversation with Robert Irene, Armada Health

Understand when total cost of care is the only winning argument - and when you can ignore it, says Oliver Wyman

Solving the payer's problem: a new key to market access

Implications for pharma are in continuing pricing pressure, and preferences for distribution channels

Express Scripts and Walgreens settle, but now 'narrow networks' are in play

Action adds to the increasing number of global healthcare-distribution pathways

Owens & Minor plans to acquire Movianto Group, a European healthcare 3PL

Although controversial, patient-focused discounts can play a valuable role in managed-markets programs

Coordinating payer contracts and direct-to-patient discounting

While 78% of survey respondents will "demand clear proof of cost savings" to ensure formulary placement, 44% of them have "little or no confidence" in the economic arguments presented by pharmacos

Business and Finance